Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Feb 27;284(6316):621–623. doi: 10.1136/bmj.284.6316.621

Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate?

K D Bardhan, D S Cole, B W Hawkins, C R Franks
PMCID: PMC1496217  PMID: 6802260

Abstract

Cimetidine 1 g daily is often continued for a fixed period beyond the time of healing of duodenal ulcer on the assumption that it might reduce the subsequent relapse rate. To test this, 194 patients whose ulcers had healed after one month of cimetidine 1 g daily were allocated at random to three groups for further treatment with cimetidine 1 g daily for two months (n = 63) or five months (n = 66) or placebo (n = 65). Thereafter all patients received placebo. Endoscopy was done routinely every three months, or earlier if symptoms recurred. During follow-up in the placebo phase, which lasted for up to 25 months, the estimated total proportions of patients in the three groups with symptomatic recurrences of ulcer were 80%, 90%, and 77%, respectively; the corresponding proportions with silent plus symptomatic relapses were 92%, 90%, and 100%. The relapse rates were also similar in all three groups. Statistical analysis showed a significant variation in relapse rate but the differences were regarded as clinically unimportant. These findings show that full-dose cimetidine continued for several months beyond the time of healing of duodenal ulcer dose not decrease the risk of subsequent relapse.

Full text

PDF
621

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodemar G., Walan A. Two-year follow-up after one year's treatment with cimetidine or placebo. Lancet. 1980 Jan 5;1(8158):38–39. doi: 10.1016/s0140-6736(80)90570-x. [DOI] [PubMed] [Google Scholar]
  2. Burland W. L., Hawkins B. W., Beresford J. Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. Postgrad Med J. 1980 Mar;56(653):173–176. doi: 10.1136/pgmj.56.653.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cargill J. M., Saunders J. H., Peden N., Wormsley K. G. Very long-term treatment of peptic ulcer with cimetidine. Lancet. 1978 Nov 25;2(8100):1113–1115. doi: 10.1016/s0140-6736(78)92273-0. [DOI] [PubMed] [Google Scholar]
  4. Clark C. G. The influence of cimetidine on current surgical treatment of peptic ulceration. Br J Clin Pract. 1979 Aug;33(8):216-9, 222. [PubMed] [Google Scholar]
  5. Clark C. J., Downie C. C. A method for the rapid determination of the number of patients to include in a controlled clinical trial. Lancet. 1966 Dec 17;2(7477):1357–1358. doi: 10.1016/s0140-6736(66)92098-8. [DOI] [PubMed] [Google Scholar]
  6. Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicentre trial. Gut. 1979 Jan;20(1):68–74. doi: 10.1136/gut.20.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Danielsson A., Ek B., Steen L. Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence. Eur J Clin Pharmacol. 1981;19(5):335–341. doi: 10.1007/BF00544583. [DOI] [PubMed] [Google Scholar]
  8. Dronfield M. W., Batchelor A. J., Larkworthy W., Langman M. J. Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects. Gut. 1979 Jun;20(6):526–530. doi: 10.1136/gut.20.6.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elashoff J. D. Combining results of clinical trials. Gastroenterology. 1978 Dec;75(6):1170–1172. [PubMed] [Google Scholar]
  10. GEHAN E. A. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965 Jun;52:203–223. [PubMed] [Google Scholar]
  11. Galeone M., Moise G., Casula P. L., Bignamini A. A. Eiie zweijährige Studie zum Auftreten von Ulkusrezidiven nach Proglumid-Therapie. Eine vergleichende Untersuchung. Med Welt. 1981 Jan 30;32(5):173–175. [PubMed] [Google Scholar]
  12. Gudmand-Høyer E., Jensen K. B., Krag E., Rask-Madsen J., Rahbek I., Rune S. J., Wulff H. R. Prophylactic effect of cimetidine in duodenal ulcer disease. Br Med J. 1978 Apr 29;1(6120):1095–1097. doi: 10.1136/bmj.1.6120.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Guslandi M., Cambielli M., Tittobello A. Carbenoxolone maintenance in cimetidine-healed patients. Scand J Gastroenterol. 1980;15(3):369–371. doi: 10.3109/00365528009181485. [DOI] [PubMed] [Google Scholar]
  14. Korman M. G., Hetzel D. J., Hansky J., Shearman D. J., Don G. Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. Dig Dis Sci. 1980 Feb;25(2):88–91. doi: 10.1007/BF01308302. [DOI] [PubMed] [Google Scholar]
  15. Martin D. F., Hollanders D., May S. J., Ravenscroft M. M., Tweedle D. E., Miller J. P. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet. 1981 Jan 3;1(8210):7–10. doi: 10.1016/s0140-6736(81)90114-8. [DOI] [PubMed] [Google Scholar]
  16. Peterson W. L., Elashoff J. Placebos in clinical trials of duodenal ulcer: the end of an era? Gastroenterology. 1980 Sep;79(3):585–588. [PubMed] [Google Scholar]
  17. Rune S. J., Greibe J., Møllman K. M., Madsen J. R., Rahbek I., Willumsen L., Wulff H. R. Recurrence of duodenal ulcer pain after treatment with cimetidine for four and eight weeks. Gut. 1980 Feb;21(2):151–153. doi: 10.1136/gut.21.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES